Study Drugs This study will be an open label study. Given its feasibility component focussing on recruitment, compliance with administration of all 3 agents, development of power estimates for future trials, further preliminary evidence of safety, and the complexity of having to blind 3 medications and having to create 3 different placebos, the investigators consider that this is the preferred initial approach in the investigational program.